“…Although spontaneous onset of ATLS does occur, the syndrome is most often associated with aggressive chemotherapy of lymphoproliferative malignancies. Factors that predispose patients to an increased risk for ATLS include not only the type of cancer (2,5), but also increased tumor mass bulk (1, 4) sensitivity to drug therapy (4), serum LDH above 600 iu (associated with areas of tumor ischemia, and used to predict tumor bulk) (2, 4, 6), renal status (1, 4), serum uric acid levels (1,4), and abdominal location of the neoplasm (1, 2, 6). There is increased risk of ATLS with any preexisting neoplastic condition that can result in either increased cell death and/or a reduced capacity to metabolize and eliminate cell breakdown products.…”